Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HYPERION DEFI, INC.EYEN · Entity 7220 | Director · 10% owner | May 14, 2019 | May 16, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HYPERION DEFI, INC.
Report date May 14, 2019 · Filed May 16, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $.0001SEC Table I · non-derivative | Direct | 33,334 |
Reported balance
After 2019-05-14 transaction · row 1
1 source rowRow 1 · 2019-05-14 · Exercise / conversion · Acquired 33,334 · Balance 33,334 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.95 · Expires 2027-07-07 | Direct | 0 |
Reported balance
After 2019-05-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-05-14 · Exercise / conversion · Disposed 33,334 · Balance 0 F2: The option became exercisable as to 2,778 shares on August 7, 2017, and becomes exercisable in equal 2,778 share amounts on each of the 11 one-month anniversaries thereafter. |
| Common Stock, par value $.0001SEC Table I · non-derivative | IndirectBy Senju Pharmaceuticals Co., Ltd. | 1,718,566 |
Reported balance
Holding disclosure · report date 2019-05-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,718,566 F1: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F2: The option became exercisable as to 2,778 shares on August 7, 2017, and becomes exercisable in equal 2,778 share amounts on each of the 11 one-month anniversaries thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2019 Filed May 16, 2019 17:19 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | Exercise / conversionStock Option (right to buy) · Derivative | 33,334 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0001638599-19-000525 · doc4_6106.xml · derivative · entry 3 Yoshida Shuhei · CIK 0001728901 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,334 shares Expires 2027-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable as to 2,778 shares on August 7, 2017, and becomes exercisable in equal 2,778 share amounts on each of the 11 one-month anniversaries thereafter. Read SEC document |
| May 14, 2019 Filed May 16, 2019 17:19 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | Exercise / conversionCommon Stock, par value $.0001 | 33,334 | $1.95 | $65,001.30 |
DisclosureSEC source: 0001638599-19-000525 · doc4_6106.xml · nonDerivative · entry 1 Yoshida Shuhei · CIK 0001728901 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2018 Filed Feb 9, 2018 10:34 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | PurchaseCommon Stock, par value $.0001 | 100,000 | $10.00 | $1,000,000.00 |
DisclosureSEC source: 0001144204-18-006804 · tv484961_4.xml · nonDerivative · entry 1 Yoshida Shuhei · CIK 0001728901 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Senju Pharmaceuticals Co., Ltd. Disclosed balance after: 1,718,566 F1 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.